|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | |
| A61K 9/08 | |||
| A61K 38/18 |
| (11) | Patento numeris | 2877201 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13822545.3 |
| Europos patento paraiškos padavimo data | 2013-07-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-06-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2013/006676 |
| Data | 2013-07-25 |
| (87) | Numeris | WO 2014/017849 |
| Data | 2014-01-30 |
| (30) | Numeris | Data | Šalis |
| 20120081478 | 2012-07-25 | KR |
| (72) |
LIM, Hyung Kyu, KR
KIM, Hyun Uk, KR
LEE, Mi Kyoung, KR
LEE, Jong Soo, KR
BAE, Sung Min, KR
KWON, Se Chang, KR
|
| (73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
| (54) | A LIQUID FORMULATION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE |
| A LIQUID FORMULATION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE |